Mercedes Herrera Department of Oncology & Pathology Karolinska Institutet Biography Publications Institution JoVE Articles Mercedes Herrera has not added a biography. If you are Mercedes Herrera and would like to personalize this page please email our Author Liaison for assistance. Publications A Snapshot of The Tumor Microenvironment in Colorectal Cancer: The Liquid Biopsy International Journal of Molecular Sciences. Nov, 2019 | Pubmed ID: 31795332 Stroma-normalised Vessel Density Predicts Benefit from Adjuvant Fluorouracil-based Chemotherapy in Patients with Stage II/III Colon Cancer British Journal of Cancer. Aug, 2019 | Pubmed ID: 31289351 A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2019 | Pubmed ID: 30850359 Endothelial Cell Activation on 3D-matrices Derived from PDGF-BB-stimulated Fibroblasts is Mediated by Snail1 Oncogenesis. Sep, 2018 | Pubmed ID: 30250018 Differential Distribution and Enrichment of Non-coding RNAs in Exosomes from Normal and Cancer-associated Fibroblasts in Colorectal Cancer Molecular Cancer. 08, 2018 | Pubmed ID: 30075793 Sistema a matrice 3D derivato da fibroblasti applicabile al saggio di formazione di tubi endoteliali Cristina Galindo-Pumariño1, Alberto Herrera2, Alberto Muñoz3, Alfredo Carrato1, Mercedes Herrera4, Cristina Peña1 1Medical Oncology Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERONC, 2Department of Medical Oncology, Hospital Universitario Puerta de Hierro de Majadahonda, 3Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid, CIBERONC, 4Department of Oncology & Pathology, Karolinska Institutet JoVE 60304 Cancer Research
Sistema a matrice 3D derivato da fibroblasti applicabile al saggio di formazione di tubi endoteliali Cristina Galindo-Pumariño1, Alberto Herrera2, Alberto Muñoz3, Alfredo Carrato1, Mercedes Herrera4, Cristina Peña1 1Medical Oncology Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERONC, 2Department of Medical Oncology, Hospital Universitario Puerta de Hierro de Majadahonda, 3Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid, CIBERONC, 4Department of Oncology & Pathology, Karolinska Institutet JoVE 60304 Cancer Research
